2021-01-08,TCR² Therapeutics Announces 2021 Strategic Priorities and Milestones
2020-12-21,TCR² Therapeutics to Present at J.P. Morgan Healthcare Conference
2020-12-14,Is TCRR A Good Stock To Buy Now?
2020-12-13,TCR² Announces RECIST Response in Ovarian Cancer from Ongoing Phase 1/2 Trial of TC-210 in Treatment Refractory Mesothelin-Expressing Solid Tumors
2020-12-11,TCR² Therapeutics to Announce Interim Data from Phase 1/2 Clinical Trial of TC-210 in Mesothelin-Expressing Solid Tumors
2020-11-12,TCR² Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-10,TCR² Therapeutics Announces Partnership with ElevateBio to Expand TC-210 Manufacturing Capacity
2020-10-27,What Type Of Shareholders Own The Most Number of TCR2 Therapeutics Inc. (NASDAQ:TCRR) Shares?
2020-10-15,Piper Sandler: These 2 Healthcare Stocks Could Be the Next M&A Target
2020-09-29,TCR² Therapeutics to Present at Jefferies Cell Therapy Virtual Summit
2020-09-08,TCR2 Therapeutics to Participate in Two Upcoming Conferences in September
2020-08-12,TCR² Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-07-28,TCR² Therapeutics Announces Pricing of Public Offering of Common Stock
2020-07-27,TCR² Therapeutics Announces Proposed Public Offering of Common Stock
2020-07-27,Why TCR2 Therapeutics Is Soaring Today
2020-07-27,TCR2 Therapeutics Releases Positive Solid Tumor Data
2020-07-27,We're Not Very Worried About TCR2 Therapeutics' (NASDAQ:TCRR) Cash Burn Rate
2020-07-26,TCR² Therapeutics Announces RECIST Responses with First TC-210 Dose Tested in Advanced Mesothelin-Expressing Solid Tumors
2020-07-24,TCR² Therapeutics to Announce Interim Data from Phase 1/2 Clinical Trial of TC-210 in Mesothelin-Expressing Solid Tumors
2020-06-17,TCR² Therapeutics to Present at the BMO Prescriptions for Success Healthcare Conference
2020-06-14,Hedge Funds Have Never Been This Bullish On TCR2 Therapeutics Inc. (TCRR)
2020-05-27,TCR² Therapeutics Hires Key Business Development and Regulatory Affairs Cell Therapy Experts to Support Strategic Objectives
2020-05-15,TCR² Therapeutics to Present Data on PD-1 Switch TRuC Enhancement at American Association for Cancer Research (AACR) Virtual Meeting 2020
2020-05-14,TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-04,TCR² Therapeutics Announces Veteran Finance Executive Stephen Webster Joins its Board of Directors
2020-04-15,TCR² Therapeutics Announces Immuno-Oncology Pioneer Dr. Axel Hoos Joins its Board of Directors
2020-04-03,TCR² Therapeutics to Present at the Goldman Sachs Cell Therapy Day
2020-03-30,TCR² Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
2020-02-18,TCR² Therapeutics to Participate in Two Upcoming Conferences in February
2020-02-03,TCR² Therapeutics to Present an Allogeneic Construct at the Keystone Symposia Conference on Emerging Cellular Therapies: Cancer and Beyond
2020-01-21,Does TCR2 Therapeutics (NASDAQ:TCRR) Have A Healthy Balance Sheet?
2020-01-07,TCR² Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-11-25,Is TCR2 Therapeutics Inc. (TCRR) A Good Stock To Buy ?
2019-11-12,TCR² Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-10-23,TCR2 Therapeutics (NASDAQ:TCRR) Is In A Good Position To Deliver On Growth Plans
2019-10-09,"Tcr² Therapeutics Appoints Industry Veteran Angela Justice, Ph.D., as Chief People Officer"
2019-09-27,TCR² Therapeutics to Present at the Cantor Global Healthcare Conference
2019-09-03,TCR2 Therapeutics Sees Hammer Chart Pattern: Time to Buy?
2019-08-30,TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2019-08-22,How Much Of TCR2 Therapeutics Inc. (NASDAQ:TCRR) Do Institutions Own?
2019-08-22,"TCR2 Therapeutics Inc. (TCRR) Shares March Higher, Can It Continue?"
2019-08-08,TCR² Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-08-06,TCR² Therapeutics to Participate in Upcoming Conferences in August
2019-08-06,TCR2 Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires
2019-07-31,TCR2 Therapeutics Announces Partnership with the National Cancer Institute for Phase 1/2 Trial of TC-210
2019-06-28,"TCR2 Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes"
2019-05-24,Who Has Been Buying TCR2 Therapeutics Inc. (NASDAQ:TCRR) Shares?
2019-05-14,TCR2 Therapeutics Inc. (TCRR) Q1 2019 Earnings Call Transcript
2019-05-13,TCR2 Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
2019-05-08,"In slow year for life science IPOs, this venture firm is making big money"
2019-05-07,TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity of the Companys Novel TRuC-T Cells
2019-04-29,TCR2 Therapeutics Announces First Quarter 2019 Earnings Conference Call and Webcast
2019-04-01,TCR2 Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
2019-03-28,TCR2 Therapeutics Presents Preclinical Data on its Lead Solid Tumor and Blood Cancer Programs at the American Association for Cancer Research (AACR) Annual Meeting
2019-03-26,TCR2 Therapeutics Announces Collaboration With Cell and Gene Therapy Catapult for the Manufacturing of its Novel T Cell Therapies for Cancer
2019-02-26,TCR2 Therapeutics Announces Exercise of Over-Allotment Option
2019-02-13,TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock
2019-02-10,IPO Outlook For The Week: Biotechs And Another Virgin Group Addition
